Peter Rands

Peter Rands is a notable inventor based in London, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of formulations for therapeutic use. With a total of 14 patents to his name, Rands has established himself as a key figure in innovation.

Latest Patents

Rands' latest patents focus on injectable and inhalable formulations. These aqueous pharmaceutical formulations comprise a salt of an optionally substituted dimethyltryptamine compound and water, with a pH ranging from 5 to 6.5. The concentration of the dimethyltryptamine compound is about 10 mg/ml or greater as the freebase equivalent. These formulations are designed for use in psychedelic-assisted therapy and can be administered through intramuscular injection or nebulized inhalation. Additionally, Rands has developed deuterated or partially deuterated N,N-dimethyltryptamine compounds, which are useful in treating psychiatric or neurological disorders. His innovative synthetic methods allow for the tailoring of therapeutic effects through varying compound amounts.

Career Highlights

Throughout his career, Rands has worked with several companies, including Small Pharma Ltd and Cybin UK Ltd. His work has focused on advancing pharmaceutical formulations that have the potential to revolutionize treatment methods for various disorders.

Collaborations

Rands has collaborated with notable individuals in the field, including Tiffanie Benway and Zelah Joel. These partnerships have contributed to the development of his innovative formulations and have enhanced the impact of his work.

Conclusion

Peter Rands is a pioneering inventor whose work in pharmaceutical formulations is paving the way for new therapeutic approaches. His contributions are significant in the realm of psychiatric and neurological treatment, showcasing the potential of innovative formulations in modern medicine.

This text is generated by artificial intelligence and may not be accurate.